Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Devimistat + Bendamustine in Relapsed/Refractory T-Cell NHL
NCT04217317Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of devimistat in T-cell non-Hodgkin lymphoma, sponsored by Wake Forest University Health Sciences. Started Sep 2020; status: terminated.
02
Drugs
devimistat
03
Conditions
T-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT04217317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217317.